格林达：2025年前三季度净利润约9229万元

Group 1 - Company Grinda reported Q3 performance with revenue of approximately 481 million yuan, a year-on-year decrease of 5.92% [1] - The net profit attributable to shareholders was about 92.29 million yuan, down 16.81% year-on-year [1] - Basic earnings per share were 0.46 yuan, reflecting a decrease of 17.25% compared to the previous year [1] Group 2 - As of the report, Grinda's market capitalization stands at 5.6 billion yuan [2] - The Chinese innovative drug sector has seen significant overseas licensing sales totaling 80 billion USD this year [2] - There is a contrast in the biopharmaceutical secondary market's activity versus the primary market, which is experiencing a fundraising slowdown [2]